IPOs - All articles

  • Jacobio Pharma lines up Hong Kong IPO

    Jacobio Pharmaceuticals is preparing to launch the roadshow for its Hong Kong IPO after winning approval to list from the city’ stock exchange last week.

    • 30 Nov 2020

  • Burger King India readies Rp8bn IPO, covers shadow book

    Burger King India is set to launch its Rp8.2bn ($110.5m) IPO this week, after having delayed the deal when the Covid-19 pandemic shut down the country’s markets in March.

    • 30 Nov 2020

  • Harbour Biomed gives Hong Kong new IPO dose

    China's Harbour Biomed, a clinical-stage biopharmaceutical company, has hit the road for its up to HK$1.8bn ($230.4m) listing.

    • 30 Nov 2020

  • JD Health to close HK$27bn IPO book early

    JD Health International is set to close the international investor book for its up-to HK$27bn ($3.5bn) IPO a day early, according to a source familiar with matter.

    • 27 Nov 2020

  • Evergrande Property Services prices HK IPO low at $1.8bn

    Evergrande Property Services Group, the property management arm of one China’s most debt-laden developers, wrapped up its IPO toward the bottom of price guidance after relying largely on Chinese investors.

    • 27 Nov 2020

  • Datang kicks off $198m Hong Kong listing

    Chinese property developer Datang Group Holdings has set its IPO in motion, opening the book for an offer that could fetch up to HK$1.5bn ($197.9m).

    • 27 Nov 2020

  • JD Health IPO has “phenomenal” first day of bookbuilding

    JD Health International launched 2020’s largest healthcare listing this week, hitting the road to raise up to HK$27bn ($3.5bn) in a Hong Kong IPO. The issuer blends healthcare and technology, two of the hottest sectors in the IPO market this year. It covered the deal multiple times on the first day. Jonathan Breen reports.

    • 26 Nov 2020

  • China Resources Mixc, Leading launch HK IPOs

    China Resources Mixc Lifestyle Services, the property management business of state-owned developer China Resources Land, kicked off bookbuilding for its Hong Kong listing this week, followed quickly by mainland-based developer Leading Holding Group.

    • 26 Nov 2020

  • Evergrande property manager finds big demand for IPO

    Evergrande Property Services Group, the property management arm of embattled developer Evergrande Group, was wrapping up its Hong Kong IPO on a strong note as GlobalCapital Asia went press, with proceeds of up to HK$15.8bn ($2bn) looking within reach.

    • 26 Nov 2020

  • China Resources Mixc eyes HK$12bn listing

    China Resources Mixc Lifestyle Services, the property management business of state-owned developer China Resources Land, has opened the book for its Hong Kong listing.

    • 25 Nov 2020

  • JD Health starts roadshow for $3.5bn IPO

    JD Health International has hit the road with an up-to HK$27bn ($3.5bn) Hong Kong IPO, set to be the largest primary listing in the city this year.

    • 25 Nov 2020

  • Tiga Spac roars with $240m from larger US IPO

    Singapore-based Tiga Acquisition Corp has raised $240m after increasing the size of its New York Stock Exchange IPO.

    • 24 Nov 2020

  • Indian regulator plans cut to minimum float for chunky IPOs

    India’s securities regulator has proposed slashing the minimum required share offering of large IPOs, helping the country’s biggest companies comply with listing rules.

    • 23 Nov 2020

  • Evergrande Property Services launches HK$16bn IPO

    China's Evergrande Property Services Group has kicked off its IPO, aiming to raise up to HK$15.8bn ($2bn) with strong support from friends-and-family investors.

    • 23 Nov 2020

  • Yatsen jumps 75% on NYSE debut

    Chinese cosmetics company Yatsen Holdings saw its shares spike 75% on their New York Stock Exchange debut on Thursday, after the firm priced its IPO at the top of the marketed range.

    • 20 Nov 2020

  • China's Yatsen launches $617m US listing

    Chinese beauty company Yatsen Holding has set its New York Stock Exchange IPO in motion, kicking off bookbuilding for a $616.9m listing.

    • 16 Nov 2020

  • Hong Kong IPOs: Four companies pre-market listings

    JD Health International, Evergrande Property Services Group, detergent maker Blue Moon Group Holdings and video marketing company Netjoy Holdings have started pre-marketing their Hong Kong IPOs.

    • 16 Nov 2020

  • Sunac Services seals $1bn HK listing at mid-point

    Chinese property management firm Sunac Services has priced its Hong Kong IPO at the middle of guidance, bagging HK$8bn ($1.03bn), according to a source close to the deal.

    • 13 Nov 2020

  • ESR readies $320m Korea Reit IPO

    South Korea-based ESR Kendall Square is set to launch a W357.3bn ($320.3m) IPO for its real estate investment trust (Reit).

    • 13 Nov 2020

  • India’s Gland Pharma scores record listing

    Gland Pharma has completed India’s largest pharmaceutical IPO, a Rp65bn ($870.6m) deal that sailed through on demand from institutional accounts. But the issuer’s Chinese ties and a wobble in pharma stocks blunted retail investor interest. Jonathan Breen reports.

    • 12 Nov 2020

  • Jinke Smart Services prices HK$5.9bn IPO at mid-point

    Jinke Smart Services Group, a Chinese property manager, raised HK$5.94bn ($766.1m) this week after sealing its IPO at the mid-point of the marketed range.

    • 12 Nov 2020

  • Fosun-backed Gland Pharma launches $876m Indian IPO

    Gland Pharma, a subsidiary of Chinese conglomerate Shanghai Fosun Pharmaceutical Group, has started bookbuilding for its Indian IPO, set to be the largest pharmaceutical listing in the country.

    • 10 Nov 2020

  • Sunac Services taps market for Hong Kong IPO

    Chinese property manager Sunac Services Holdings has hit the road for its Hong Kong listing, eyeing HK$8.7bn ($1.1bn) in fresh equity.

    • 09 Nov 2020

  • China Resources’ property manager pre-markets $1bn HK IPO

    China Resources Mixc Lifestyle Services has begun testing investor appetite for a Hong Kong listing that could raise around $1bn, said a source close to the deal.

    • 09 Nov 2020

  • Antengene targets HK$2.8bn from Hong Kong IPO

    Antengene Corp, a clinical stage biopharmaceutical company, has set its Hong Kong listing in motion. It has opened bookbuilding for an up to HK$2.79bn ($359.4m) IPO.

    • 09 Nov 2020

  • Blank check firm Tiga Investments targets US IPO

    Singapore-based special purpose acquisition company (Spac) Tiga Acquisition Corp has set in motion a $200m listing on the New York Stock Exchange.

    • 06 Nov 2020

  • Tencent-backed Kuaishou eyes Hong Kong bourse

    Chinese video-sharing platform Kuaishou Technology is planning to float in Hong Kong, having filed a draft prospectus with the city’s stock exchange.

    • 06 Nov 2020

  • Antengene readies Hong Kong listing

    Antengene Corp, a clinical stage biopharmaceutical company, is set to launch the roadshow for its Hong Kong IPO next week after wrapping up pre-deal investor education, according to a source close to the listing.

    • 06 Nov 2020

  • China stuns market by halting Ant IPO at the eleventh hour

    The Shanghai Stock Exchange stunned the market on Tuesday by halting Ant Group’s $34bn IPO, set to be the largest listing in history, just two days before the company’s planned stock market debut. The extraordinary move is expected to delay the listing by at least six months. It will also force investors to revalue the company, write Jonathan Breen and Addison Gong.

    • 05 Nov 2020

  • Jinke hits the road with $816m Hong Kong IPO

    Chinese property manager Jinke Smart Services Group has launched its IPO. It is aiming to pocket up to HK$6.3bn ($815.9m) from the deal.

    • 05 Nov 2020

  • China’s move against Ant Group is a gift to its critics

    China’s decision to clamp down on Ant Group has derailed an IPO of at least $34bn, despite execution being finished last week. The move appears to be little more than political muscle-flexing by Beijing. The real winners will be the country’s critics.

    • 05 Nov 2020

  • Fosun-backed Gland Pharma readies Rp65bn IPO

    Gland Pharma, a subsidiary of Shanghai Fosun Pharmaceutical Group, has set the final terms for its Rp64.8bn ($866.5m) IPO in India.

    • 04 Nov 2020

  • RemeGen nets $515m from Hong Kong IPO

    Chinese biopharmaceutical firm RemeGen has raised HK$3.99bn ($514.7m) after pricing its IPO at the top of the marketed range, according to a source familiar with the matter.

    • 04 Nov 2020

  • China pulls plug on Ant Group IPO

    The Shanghai bourse stunned the market on Tuesday after halting Ant Group’s $34bn IPO, a deal which was set to be the largest listing in history. The extraordinary move, likely spurred by comments from Ant’s co-founder Jack Ma that criticised authorities for stifling innovation in China, is expected to delay the listing by at least six months. It will also force investors to revalue the company.

    • 04 Nov 2020

  • New Oriental guides HK secondary listing to $1.3bn

    New Oriental Education & Technology Group is set to raise HK$10.1bn ($1.3bn) as it guides investors toward final pricing for its secondary offering in Hong Kong.

    • 03 Nov 2020

  • Sunkwan Properties targets HK$1.3bn listing

    Chinese developer Sunkwan Properties has kicked off its IPO roadshow. It is aiming to raise up to HK$1.25bn ($161.2m).

    • 02 Nov 2020